Immodulon Therapeutics Limited

POWER SEARCH PRICING

SOLUTIONS

immodulon therapeutics limited Company Information

Live

EstablishedSmallHealthy

Company Number

06223291

Website

www.immodulon.com

Registered Address

6-9 the square, stockley park, uxbridge, middlesex, UB11 1FW

Industry

Other research and experimental development on natural sciences and engineering

Other human health activities

Telephone

02031376346

Next Accounts Due

September 2024

Group Structure

View All

Directors

Anthony Bolton9 Years

Simon Robertson9 Years

View All

Shareholders

lifexx sa 27.5%

anthony john bolton 15.7%

View All

immodulon therapeutics limited Estimated Valuation

£4.2m

Pomanda estimates the enterprise value of IMMODULON THERAPEUTICS LIMITED at £4.2m based on Net Assets of £1.8m and 2.31x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Immodulon Therapeutics Limited is a live company located in uxbridge, UB11 1FW with a Companies House number of 06223291. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in April 2007, it's largest shareholder is lifexx sa with a 27.5% stake. Immodulon Therapeutics Limited is a established, small sized company, Pomanda has estimated its turnover at £1.1m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Immodulon Therapeutics Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating4.5out of 5

4 Strong

3 Regular

3 Weak

Size

annual sales of £1.1m, make it smaller than the average company (£2.6m)

Growth

3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (4.2%)

EXPORT

Immodulon Therapeutics Limited's latest turnover from December 2022 is estimated at £1.1 million and the company has net assets of £1.8 million. According to their latest financial statements, Immodulon Therapeutics Limited has 4 employees and maintains cash reserves of £1.7 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2022	Dec 2021	Dec 2020	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	1,147,771	2,447,069	1,275,449	979,423	810,160	736,059	1,840,598	1,336,280	6,956,456	8,294,295	6,284,856	942,766	917,708	403,991
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	678,883	1,491,273	788,097	573,048	473,482	427,824	1,056,381	776,167	4,063,298	4,876,040	3,608,516	538,154	507,291	228,620
Gross Profit	468,887	955,796	487,352	406,375	-2,208,208	-285,966	784,217	560,113	2,893,158	3,418,255	2,676,340	404,612	410,417	175,372
Admin Expenses	3,928,444	5,622,948	6,596,245	3,928,320	1,045,143	3,543,344	5,074,003	5,018,050	5,638,892	7,236,290	5,994,558	3,732,190	3,363,011	5,193,358
Operating Profit	-3,459,557	-4,667,152	-6,108,893	-3,521,945	-3,253,351	-3,829,310	-4,289,786	-4,457,937	-2,745,734	-3,818,035	-3,318,218	-3,327,578	-2,952,594	-5,017,986
Interest Payable	0	0	0	0	0	5	0	0	0	0	0	0	0	0
Interest Receivable	62,852	2,794	2,283	2,741	11,372	4,512	10,804	27,449	23,488	21,377	17,973	14,669	22,016	12,276
Pre-Tax Profit	-3,396,705	-4,664,358	-6,106,610	-3,519,204	-3,241,979	-3,824,803	-4,278,982	-4,430,488	-2,722,246	-3,796,658	-3,300,245	-3,312,909	-2,930,578	-5,005,710
Tax	0	0	0	0	626,638	959,348	0	0	0	0	0	0	0	0
Profit After Tax	-3,396,705	-4,664,358	-6,106,610	-3,519,204	-2,615,341	-2,865,455	-4,278,982	-4,430,488	-2,722,246	-3,796,658	-3,300,245	-3,312,909	-2,930,578	-5,005,710
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-3,396,705	-4,664,358	-6,106,610	-3,519,204	-2,615,341	-2,865,455	-4,278,982	-4,430,488	-2,722,246	-3,796,658	-3,300,245	-3,312,909	-2,930,578	-5,005,710
Employee Costs	170,512	248,267	239,764	234,618	191,276	152,538	144,876	143,173	4,552,788	5,084,565	3,932,496	605,613	597,517	261,643
Number Of Employees	4	6	6	6	5	4	4	4	128	150	115	18	18	8
EBITDA*	-3,459,128	-4,666,579	-6,108,435	-3,521,030	-3,252,130	-3,827,681	-4,287,616	-4,455,042	-2,741,875	-3,813,941	-3,313,605	-3,323,282	-2,946,865	-5,015,193

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2022	Dec 2021	Dec 2020	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	1,288	1,717	2,290	2,748	3,663	4,884	6,513	8,683	11,578	12,283	13,839	12,891	17,187	8,377
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	8,704	194,872	194,872	194,872	194,827	186,168	186,168	186,168	186,168	186,168	186,168	186,168	186,168	186,168
Debtors (Due After 1 year)	0	577,501	593,244	0	0	0	1,198,435	1,058,915	0	0	0	0	0	0
Total Fixed Assets	9,992	774,090	790,406	197,620	198,490	191,052	1,391,116	1,253,766	197,746	198,451	200,007	199,059	203,355	194,545
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	0	0	0	0	0	0	251,855	184,580	847,659	1,098,402	696,764	53,436	103,599	31,865
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	1,102,541	584,697	1,888,219	1,661,506	818,760	1,075,993	0	0	0	0	0	0	0	0
Cash	1,710,115	1,881,402	353,474	1,270,066	4,212,554	4,061,137	3,724,826	4,917,997	6,061,687	3,333,397	5,217,301	1,971,809	3,895,844	4,910,501
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	2,812,656	2,466,099	2,241,693	2,931,572	5,031,314	5,137,130	3,976,681	5,102,577	6,909,346	4,431,799	5,914,065	2,025,245	3,999,443	4,942,366
total assets	2,822,648	3,240,189	3,032,099	3,129,192	5,229,804	5,328,182	5,367,797	6,356,343	7,107,092	4,630,250	6,114,072	2,224,304	4,202,798	5,136,911
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	509,152	1,114,831	483,670	371,619	326,098	281,315	645,613	455,177	525,438	326,350	412,714	223,501	89,086	92,621
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	492,065	407,222	416,121	37,859	267,911	35,325	0	0	0	0	0	0	0	0
total current liabilities	1,001,217	1,522,053	899,791	409,478	594,009	316,640	645,613	455,177	525,438	326,350	412,714	223,501	89,086	92,621
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	1,001,217	1,522,053	899,791	409,478	594,009	316,640	645,613	455,177	525,438	326,350	412,714	223,501	89,086	92,621
net assets	1,821,431	1,718,136	2,132,308	2,719,714	4,635,795	5,011,542	4,722,184	5,901,166	6,581,654	4,303,900	5,701,358	2,000,803	4,113,712	5,044,290
total shareholders funds	1,821,431	1,718,136	2,132,308	2,719,714	4,635,795	5,011,542	4,722,184	5,901,166	6,581,654	4,303,900	5,701,358	2,000,803	4,113,712	5,044,290

	Dec 2022	Dec 2021	Dec 2020	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	-3,459,557	-4,667,152	-6,108,893	-3,521,945	-3,253,351	-3,829,310	-4,289,786	-4,457,937	-2,745,734	-3,818,035	-3,318,218	-3,327,578	-2,952,594	-5,017,986
Depreciation	429	573	458	915	1,221	1,629	2,170	2,895	3,859	4,094	4,613	4,296	5,729	2,793
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	0	0	626,638	959,348	0	0	0	0	0	0	0	0
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	-59,657	-1,319,265	1,662,703	842,746	-257,233	-374,297	206,795	395,836	-250,743	401,638	643,328	-50,163	71,734	31,865
Creditors	-605,679	631,161	157,572	45,521	44,783	-364,298	190,436	-70,261	199,088	-86,364	189,213	134,415	-3,535	92,621
Accruals and Deferred Income	84,843	-8,899	148,210	-230,052	232,586	35,325	0	0	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-3,920,307	-2,725,052	-7,465,356	-4,548,307	-2,090,890	-2,823,009	-4,303,975	-4,921,139	-2,292,044	-4,301,943	-3,767,720	-3,138,704	-3,022,134	-4,954,437
Investing Activities
capital expenditure	0	0	915	0	0	0	0	0	-3,154	-2,538	-5,561	0	-14,539	-11,170
Change in Investments	-186,168	0	45	45	8,659	0	0	0	0	0	0	0	0	186,168
cash flow from investments	186,168	0	870	-45	-8,659	0	0	0	-3,154	-2,538	-5,561	0	-14,539	-197,338
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	3,500,000	4,250,186	3,603,123	1,603,123	2,239,594	3,154,813	3,100,000	3,750,000	5,000,000	2,399,200	7,000,800	1,200,000	2,000,000	10,050,000
interest	62,852	2,794	2,283	2,741	11,372	4,507	10,804	27,449	23,488	21,377	17,973	14,669	22,016	12,276
cash flow from financing	3,562,852	4,252,980	3,605,406	1,605,864	2,250,966	3,159,320	3,110,804	3,777,449	5,023,488	2,420,577	7,018,773	1,214,669	2,022,016	10,062,276
cash and cash equivalents
cash	-171,287	1,527,928	-3,859,080	-2,942,488	151,417	336,311	-1,193,171	-1,143,690	2,728,290	-1,883,904	3,245,492	-1,924,035	-1,014,657	4,910,501
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-171,287	1,527,928	-3,859,080	-2,942,488	151,417	336,311	-1,193,171	-1,143,690	2,728,290	-1,883,904	3,245,492	-1,924,035	-1,014,657	4,910,501

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for immodulon therapeutics limited. Get real-time insights into immodulon therapeutics limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for immodulon therapeutics limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

IMMODULON THERAPEUTICS LIMITED group structure

Immodulon Therapeutics Limited has no subsidiary companies.

Ultimate parent company

IMMODULON THERAPEUTICS LIMITED

06223291

IMMODULON THERAPEUTICS LIMITED Shareholders

lifexx sa	27.47%
anthony john bolton	15.66%
charles assad akle	13.6%
sarah bolton	8.59%
bartlett international holdings limited	5.83%
ronnie alexander bartlett	3.1%
executors of the estate of john lawson stanford	2.78%
cynthia ann stanford	2.78%
helga grange	2.72%
satvinder singh mudan	2.72%

Immodulon Therapeutics Limited currently has 6 directors. The longest serving directors include Mr Anthony Bolton (Mar 2015) and Sir Simon Robertson (May 2015).

officer	country	age	start	end	role
Mr Anthony Bolton		74 years	Mar 2015	-	Director
Sir Simon Robertson		83 years	May 2015	-	Director
Dr Selwyn Ho	England	53 years	Jun 2022	-	Director
Mr Gertjan Bartlema	England	52 years	Jun 2022	-	Director
Dr Joseph Mason	England	58 years	Sep 2022	-	Director
Mr Richard Davies	England	63 years	Apr 2023	-	Director

P&L

December 2022

turnover

1.1m

-53%

operating profit

-3.5m

gross margin

40.9%

+4.59%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

1.8m

+0.06%

total assets

2.8m

-0.13%

cash

1.7m

-0.09%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

visioncare research limited

4.5

helloself ltd

lister institute of preventive medicine(the)

medical detection dogs

4.5

harley academy limited

2.5

company number

06223291

Type

Private limited with Share Capital

industry

72190 - Other research and experimental development on natural sciences and engineering

86900 - Other human health activities

incorporation date

April 2007

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

address

6-9 the square, stockley park, uxbridge, middlesex, UB11 1FW

last accounts submitted

December 2022

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to immodulon therapeutics limited. Currently there are 4 open charges and 0 have been satisfied in the past.

immodulon therapeutics limited Company Information

immodulon therapeutics limited Estimated Valuation

immodulon therapeutics limited Estimated Valuation

immodulon therapeutics limited Estimated Valuation

Immodulon Therapeutics Limited Overview

Immodulon Therapeutics Limited Health Check

IMMODULON THERAPEUTICS LIMITED financials

immodulon therapeutics limited Credit Report and Business Information

Immodulon Therapeutics Limited Competitor Analysis

immodulon therapeutics limited Ownership

immodulon therapeutics limited directors

immodulon therapeutics limited company details

immodulon therapeutics limited Charges & Mortgages

immodulon therapeutics limited Companies House Filings - See Documents